We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
News and Views.
- Authors
Idris, Iskandar
- Abstract
The article offers news briefs related to diabetes, metabolism and obesity. The European Commission (EU) has approved the use of the Levemir® from Novo Nordisk A/S in children with type 1 diabetes. The survey funded by Novo Nordisk A/S on diabetics in Great Britain has found that a thid of the 1,000 diabetics experience an 5 hypoglycaemic episodes on average per month. Takeda Pharmaceutical Co. has announced that the TAK-875 will undergo a Phase 3 clinical trial program.
- Subjects
EUROPEAN Commission; TREATMENT of diabetes; TYPE 1 diabetes; NOVO Nordisk A/S; SURVEY methodology; PEOPLE with diabetes; TAKEDA Pharmaceutical Co. Ltd.; CLINICAL trials; HEALTH
- Publication
Diabetes, Obesity & Metabolism, 2012, Vol 14, Issue 1, p97
- ISSN
1462-8902
- Publication type
Article
- DOI
10.1111/j.1463-1326.2011.01541.x